Axsome Therapeutics Insider Trades

AXSM

Track insider trading activity from Axsome Therapeutics executives and directors. See which insiders are buying and selling AXSM stock.

Trades Last 12 Months

AXSM Price

All Insider Trades for Axsome Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tabuteau Herriot 10% owner, Chief Executive Officer
Holding Value $13.4M 56,895 shares
Last Trade
Jul 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12M 49,666 shares
$240.66
$235.26
Jeffs Roger Director
Holding Value $13.7M 58,367 shares
Last Trade
Jun 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$71.2k 286 shares
$249.12
$235.26
Coleman Mark Director
Holding Value $7.15M 30,389 shares
Last Trade
Jun 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$160k 643 shares
$249.00
$235.26
Mahony Susan Director
Holding Value $195k 829 shares
Last Trade
Jun 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$73.9k 300 shares
$246.18
$235.26
Pizzie Nick Chief Financial Officer
Holding Value $16.9M 72,000 shares
Last Trade
Jun 09, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.11M 33,000 shares
$245.64
$235.26
Saad Mark E Director
Holding Value $0 0 shares
Last Trade
Jun 08, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$336k 1,429 shares
$235.14
$235.26
Jacobson Mark L. Chief Operating Officer
Holding Value $27M 114,954 shares
Last Trade
May 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$52k 233 shares
$223.06
$235.26
Maizel Ari Chief Commercial Officer
Holding Value $1.76M 7,500 shares
Last Trade
Apr 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.4M 7,500 shares
$186.42
$235.26
Tabuteau Herriot 10% owner, Chief Executive Officer
Holding Value $5.67M 24,081 shares
Last Trade
Apr 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.41M 24,081 shares
$182.97
$235.26
Murdock Hunter R. General Counsel
Holding Value $1.7M 7,224 shares
Last Trade
Apr 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.32M 7,224 shares
$182.97
$235.26
Jeffs Roger Director
Holding Value $13.5M 57,510 shares
Last Trade
Sep 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.67M 13,464 shares
$123.68
$235.26
Marek David C Chief Commercial Officer
Holding Value $12.7M 53,984 shares
Last Trade
Mar 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.18M 70,517 shares
$45.14
$235.26
Potter Myrtle S Director
Holding Value $3.06M 13,000 shares
Last Trade
Jun 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$286k 13,000 shares
$22.03
$235.26
Ames Constance Vice President, Finance
Holding Value $5.88M 25,000 shares
Last Trade
Mar 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 25,000 shares
$4.95
$235.26
Kaye Randall Chief Medical Officer
Holding Value $1.42M 6,022 shares
Last Trade
Dec 23, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.03k 1,000 shares
$9.03
$235.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up